Antidiabetic and Antihyperlipidemic Activities of the Leaf Latex Extract of Aloe megalacantha Baker (Aloaceae) in Streptozotocin-Induced Diabetic Model

Table 3

The effects of the leaf latex extract of Aloe megalacantha in STZ-induced diabetic mice.

Groups	Blood glucose level in mg/dL
	Day 0	Day 7	Day 14
NC	101.33 ± 4.07	99.83 ± 3.20	102.33 ± 3.88
DC	264.33 ± 5.49	266.83 ± 1.13	268.83 ± 5.05
GL5	256.33 ± 4.63	219.50 ± 4.28	191.67 ± 1.58
AM100	265.33 ± 7.67	241.50 ± 6.55	203.83 ± 2.35
AM200	262.17 ± 5.29	239.50 ± 7.10	204.00 ± 1.96
AM400	265.50 ± 9.86	241.17 ± 6.94	202.00 ± 1.88

Results are expressed in mean ± S.E.M, n = 6; DW10 = distilled water 10 ml/kg; DC = diabetic control; GL5 = glibenclamide 5 mg/kg; AM100 = A. megalacantha extract 100 mg/kg; AM200 = A. megalacantha extract 200 mg/kg; AM400 = A. megalacantha extract 400 mg/kg; compared with diabetic control group, compared to 0 days, compared to 7 days, ¹p < 0.05, ²p < 0.01, ³p < 0.001.